Lung cancer

Summary

The NICE lung cancer clinical guideline covers the full range of care that should be available from the NHS to adults who have lung cancer, or whose doctors think they may have lung cancer. They include how the diagnosis should be made and the treatments that should be offered at different times.

The guideline does not look at:

• mesothelioma (a type of cancer affecting the lining of the lung)
• cancer that starts in a different part of the body and then spreads to the lungs
• children

This guidance replaces and incorporates TA26 Lung cancer - docetaxel, paclitaxel, gemcitabine and vinorelbine.

Documents

For healthcare professionals

• CG24 Lung cancer: Full guideline, appendices
• CG24 Lung cancer: Full guideline
• CG24 Lung cancer: Quick reference guide
• CG24 Lung cancer: NICE guideline (Word version)
• CG24 Lung cancer: NICE guideline

For patients, carers and the public

• CG24 Lung cancer: Information for the public

Background information

• CG24 Lung cancer: Distribution list
• 2005/004 New guideline from NICE will improve diagnosis and treatment of lung cancer
• Scope for the development of a clinical guideline on the diagnosis and treatment of lung cancer

Implementing this guidance

Any further information NICE has produced to help the NHS implement this guideline locally is linked to below:

• CG24 Lung cancer: Costing template (Wales)
• CG24 Lung cancer: Costing template (England)
• CG24 Lung cancer: Cost impact report